466 related articles for article (PubMed ID: 33759566)
1. Modeling pancreatic pathophysiology using genome editing of adult stem cell-derived and induced pluripotent stem cell (iPSC)-derived organoids.
Hirshorn ST; Steele N; Zavros Y
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1142-G1150. PubMed ID: 33759566
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas 9 genome editing and its applications in organoids.
Driehuis E; Clevers H
Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G257-G265. PubMed ID: 28126704
[TBL] [Abstract][Full Text] [Related]
3. Genetic engineering in organoids.
Teriyapirom I; Batista-Rocha AS; Koo BK
J Mol Med (Berl); 2021 Apr; 99(4):555-568. PubMed ID: 33459801
[TBL] [Abstract][Full Text] [Related]
4. Modeling of Autism Using Organoid Technology.
Choi H; Song J; Park G; Kim J
Mol Neurobiol; 2017 Dec; 54(10):7789-7795. PubMed ID: 27844287
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids.
Hendriks D; Clevers H; Artegiani B
Cell Stem Cell; 2020 Nov; 27(5):705-731. PubMed ID: 33157047
[TBL] [Abstract][Full Text] [Related]
6. Applications of kidney organoids derived from human pluripotent stem cells.
Kim YK; Nam SA; Yang CW
Korean J Intern Med; 2018 Jul; 33(4):649-659. PubMed ID: 29961307
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
8. Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology.
Kim J; Koo BK; Yoon KJ
Viruses; 2019 Jan; 11(2):. PubMed ID: 30704043
[TBL] [Abstract][Full Text] [Related]
9. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids.
Costamagna G; Comi GP; Corti S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800815
[TBL] [Abstract][Full Text] [Related]
10. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
Ho BX; Pek NMQ; Soh BS
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
[TBL] [Abstract][Full Text] [Related]
11. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
[TBL] [Abstract][Full Text] [Related]
12. Studying Kidney Disease Using Tissue and Genome Engineering in Human Pluripotent Stem Cells.
Garreta E; González F; Montserrat N
Nephron; 2018; 138(1):48-59. PubMed ID: 28988229
[TBL] [Abstract][Full Text] [Related]
13. A genome-scale CRISPR screen reveals factors regulating Wnt-dependent renewal of mouse gastric epithelial cells.
Murakami K; Terakado Y; Saito K; Jomen Y; Takeda H; Oshima M; Barker N
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33479180
[TBL] [Abstract][Full Text] [Related]
14. Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids.
Ramakrishna G; Babu PE; Singh R; Trehanpati N
Hepatol Int; 2021 Dec; 15(6):1309-1317. PubMed ID: 34596864
[TBL] [Abstract][Full Text] [Related]
15. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
Lee CT; Bendriem RM; Wu WW; Shen RF
J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
[TBL] [Abstract][Full Text] [Related]
16. Human Organoid and Supporting Technologies for Cancer and Toxicological Research.
Sekine K
Front Genet; 2021; 12():759366. PubMed ID: 34745227
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
18. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
19. [Current researches and prospects of human induced pluripotent stem cells and gene editing technology of CRISPR/Cas9 in inherited ocular diseases].
Fan F; Wu JH; Luo Y
Zhonghua Yan Ke Za Zhi; 2021 Sep; 57(9):712-716. PubMed ID: 34865411
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-Mediated Genome Editing of Mouse Small Intestinal Organoids.
Schwank G; Clevers H
Methods Mol Biol; 2016; 1422():3-11. PubMed ID: 27246017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
